4th Annual Life Sciences Patent Network (LSPN) North America Fall Conference 2023

| October.10.2023 | 9:40am - 10:00am (Pacific Daylight Time)

San Francisco

Orrick is proud to sponsor LSPN's 2023 North America Fall Conference, where Lauren Drake will be presenting on the US Patent Landscape and Gargi Talukder will be presenting on best practices in invention harvesting and managing collaborative IP.

LSPN's North America Fall Conference tackles the latest challenges in protecting innovation in the pharmaceutical and biotechnology industry. Every year, hundreds of IP professionals rely on Life Sciences Patent Network conferences to get insights into sector issues of critical importance and stay abreast of the likely forward impact of key judgements and political jolts.

Veranstaltungen

Contacts

Lauren Drake Partner

Los Angeles

See my bio

D:+1 213 612 2379
E: [email protected]

vCard

See full bio

Lauren Drake Partner

Los Angeles

Lauren has represented clients in connection with a broad spectrum of technologies, ranging from central nervous system stimulants to immunotherapies and monoclonal antibody medications to anti-angiogenesis drugs in the pharmaceutical and biotechnology industries.

She was recognized by Law360’s Rising Stars as “one of the top intellectual property attorneys under the age of 40” in 2019. Lauren was also named to Benchmark Litigation’s "40 and Under Hot List," which honors the achievements of the nation’s most accomplished litigators under 40.

Gargi Talukder Partner, Geistiges Eigentum, Life Sciences

San Francisco

See my bio

D:+1 415 773 5625
E: [email protected]

Practice:

Life Sciences Sector
Geistiges Eigentum
Life Sciences
Patents

vCard

See full bio

Gargi Talukder Partner

San Francisco

Gargi’s work in protein therapeutics includes patent estate development for antibody and fusion protein therapeutics and utilizes her knowledge of the patent landscape in this area to inform strategic portfolio management. In the fields of genomics and proteomics, she has conducted diligence and developed portfolios related to the biochemistry of sequencing technologies, as well as to the associated devices and machine learning methods utilized in sequencing methods. In the field of cancer immunotherapies (immuno-oncology), she has developed portfolios related to cell-based immunotherapy approaches, including targeted immune cell therapies and immunological pathway interventions.

In addition, Gargi assists clients in providing intellectual property support for transactional matters, including diligence for mergers and acquisitions as well as financing rounds. Her technical experience is routinely called upon in helping to develop litigation strategies for complex and high-stakes trials.

Gargi has authored scientific papers in peer-reviewed publications, as well as articles discussing medical and biological research in general-interest newspapers and periodicals. Her doctoral work in Neuroscience from Stanford University focused on structure-function studies in ion channels, with an emphasis on using genetic engineering and electrophysiology to identify structural elements of potassium channels that lead to their voltage and chemical sensitivity.

Related Areas

Markets

Bay Area: San Francisco and Silicon Valley